Go Back Email this Link to a friend

Competition Commission Recommends Conditional Approval Of BIDCO And Afrox

Release Date: 20/04/2004 14:17:02      Code(s): AFX
Competition Commission Recommends Conditional Approval Of BIDCO And Afrox       
Healthcare Deal                                                                 
African Oxygen Limited                                                          
(Incorporated in the Republic of South Africa)                                  
(Registration number 1927/000089/06)                                            
Share code: AFX                                                                 
ISIN: ZAE000030920                                                              
African Oxygen Limited (Afrox) wishes to notify all its shareholders and        
interested parties that, on Friday 16 April 2004, the Competition Commission    
recommended to the Competition Tribunal that the merger of Business Venture     
Investments No 790 (Pty) Ltd  (Bidco) and Afrox Healthcare Limited (Ahealth) be 
approved subject to certain conditions.                                         
Bidco comprises a BEE consortium and Medi-Clinic Corporation Limited (Medi-     
Clinic). The BEE consortium comprises Brimstone Investment Corporation Limited, 
Mvelaphanda Strategic Investments (Pty) Ltd (Mvelaphanda), and broad based      
empowerment groupings.                                                          
The summary of the salient points of the conditions recommended by the          
Competition Commission are -                                                    
-    Disinvestment of Mvelaphanda"s shareholding in Tshwane Private Hospitals   
(Pty) Ltd (Tshwane)                                                             
     -    Mvelaphanda must disinvest its 32 percent shareholding in Tshwane.    
-    Appointment of a non-executive director by Medi-Clinic to Bidco board      
-    The non-executive director to be appointed by Medi-Clinic to the board
of Bidco shall be an independent director and shall not be a serving member of  
the board of either Medi-Clinic or Remgro Limited.                              
-    Future hospital acquisitions by Medi-Clinic                                
-    Medi-Clinic must notify the Competition Commission of all future      
hospital acquisitions.                                                          
For further details please access the Competition Commission website at         
The approval by the Competition Tribunal is the only outstanding condition      
precedent for the acquisition by Bidco of all the shares in Ahealth, including  
Afrox"s 69 percent shareholding in Ahealth. Should the transaction be           
conditionally approved by the Competition Tribunal, Afrox shall be entitled to  
accept such conditional approval and by doing so, bring about the fulfillment of
the last condition precedent.                                                   
Issued by African Oxygen Limited                                                
For further information                                                         
Chris Fieldgate     (011) 490-0430 / 082 495 1481                               
Ros Beart           (011) 490 0712 / 082 891 5149                               
Date: 20/04/2004 02:17:07 PM Supplied by www.sharenet.co.za                     
Produced by the JSE SENS Department                                             

Email this JSE Sens Item to a Friend.

Send e-mail to
© 2018 SHARENET (PTY) Ltd, Cape Town, South Africa
Home     Terms & conditions    Privacy Policy
    Security Notice    Contact Details
Market Statistics are calculated by Sharenet and are therefore not the official JSE Market Statistics. The calculation/derivation may include underlying JSE data.